These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8983284)

  • 41. Efficacy of twice daily versus three times daily oral ondansetron in the prevention of chemotherapy induced emesis: a randomized, single-blind, multicentre study. The Ondansetron International Emesis Study Group.
    Dicato MA; Kaasa S; Campora E; Bleiberg H; Warnier P; Vindevoghel A; Cunningham D; Liebhard A; Upadhyaya BK
    Clin Oncol (R Coll Radiol); 1992 Sep; 4(5):275-9. PubMed ID: 1390340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized, double-blind, crossover, placebo-controlled trial of intravenous ondansetron for the prevention of intrathecal chemotherapy-induced vomiting in children.
    Parker RI; Prakash D; Mahan RA; Giugliano DM; Atlas MP
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):578-81. PubMed ID: 11902300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Dolasetron Comparative Study Group.
    Fauser AA; Duclos B; Chemaissani A; Del Favero A; Cognetti F; Diaz-Rubio E; Cortes-Funes H; Conte PF; Dressler H
    Eur J Cancer; 1996 Aug; 32A(9):1523-9. PubMed ID: 8911112
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy.
    Smith DB; Newlands ES; Rustin GJ; Begent RH; Howells N; McQuade B; Bagshawe KD
    Lancet; 1991 Aug; 338(8765):487-90. PubMed ID: 1714532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.
    Saito M; Aogi K; Sekine I; Yoshizawa H; Yanagita Y; Sakai H; Inoue K; Kitagawa C; Ogura T; Mitsuhashi S
    Lancet Oncol; 2009 Feb; 10(2):115-24. PubMed ID: 19135415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ondansetron versus granisetron in the prevention of chemotherapy induced nausea and vomiting in children with acute lymphoblastic leukemia.
    Siddique R; Hafiz MG; Rokeya B; Jamal CY; Islam A
    Mymensingh Med J; 2011 Oct; 20(4):680-8. PubMed ID: 22081189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized double-blind comparison of three dose levels of intravenous ondansetron in the prevention of cisplatin-induced emesis.
    Grunberg SM; Lane M; Lester EP; Sridhar KS; Mortimer J; Murphy W; Sanderson PE
    Cancer Chemother Pharmacol; 1993; 32(4):268-72. PubMed ID: 8324868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prospective randomized trial of the antiemetic efficacy and cost-effectiveness of intravenous and orally disintegrating tablet of ondansetron in children with cancer.
    Corapçioglu F; Sarper N
    Pediatr Hematol Oncol; 2005 Mar; 22(2):103-14. PubMed ID: 15804995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy.
    Audhuy B; Cappelaere P; Martin M; Cervantes A; Fabbro M; Rivière A; Khayat D; Bleiberg H; Faraldi M; Claverie N; Aranda E; Auclerc G; Audhuy B; Benhammouda A; Bleiberg H; Cals L; Cappelaere P; Cattan A; Cervantes A; Chevallier B; Conroy T; Cupissol D; De Grève J; Diaz-Rubio E; Seitz JF
    Eur J Cancer; 1996 May; 32A(5):807-13. PubMed ID: 9081358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Anti-emetic effect and safety of single dose of ondansetron injection in double-blind comparison study with placebo].
    Ohta J; Taguchi T; Furue H; Niitani H; Ota K; Tsukagoshi S; Ariyoshi Y; Ikeda M; Akasaka Y; Suminaga M
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):2041-55. PubMed ID: 1417013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
    Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups.
    Fortney JT; Gan TJ; Graczyk S; Wetchler B; Melson T; Khalil S; McKenzie R; Parrillo S; Glass PS; Moote C; Wermeling D; Parasuraman TV; Duncan B; Creed MR
    Anesth Analg; 1998 Apr; 86(4):731-8. PubMed ID: 9539593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 5-HT3 antagonist ondansetron--an effective outpatient antiemetic in cancer treatment.
    Pinkerton CR; Williams D; Wootton C; Meller ST; McElwain TJ
    Arch Dis Child; 1990 Aug; 65(8):822-5. PubMed ID: 2144721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy.
    Jones AL; Hill AS; Soukop M; Hutcheon AW; Cassidy J; Kaye SB; Sikora K; Carney DN; Cunningham D
    Lancet; 1991 Aug; 338(8765):483-7. PubMed ID: 1678453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens.
    Martoni A; Angelelli B; Guaraldi M; Strocchi E; Pannuti F
    Eur J Cancer; 1996 Jan; 32A(1):82-5. PubMed ID: 8695248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer.
    Herrstedt J; Sigsgaard T; Handberg J; Schousboe BM; Hansen M; Dombernowsky P
    J Clin Oncol; 1997 Apr; 15(4):1690-6. PubMed ID: 9193370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Granisetron (IV) compared with ondansetron (IV plus oral) in the prevention of nausea and vomiting induced by moderately-emetogenic chemotherapy. A cross-over study.
    Bonneterre J; Hecquet B
    Bull Cancer; 1995 Dec; 82(12):1038-43. PubMed ID: 8745670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravenous ondansetron plus intravenous dexamethasone with different ondansetron dosing schedules during multiple cycles of cisplatin-based chemotherapy.
    Chen PT; Liaw CC
    Chang Gung Med J; 2008; 31(2):167-74. PubMed ID: 18567417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
    Jeremić B
    Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pilot study of ondansetron plus metopimazine vs. ondansetron monotherapy in children receiving highly emetogenic chemotherapy: a Bayesian randomized serial N-of-1 trials design.
    Nathan PC; Tomlinson G; Dupuis LL; Greenberg ML; Ota S; Bartels U; Feldman BM
    Support Care Cancer; 2006 Mar; 14(3):268-76. PubMed ID: 16052316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.